Close

IIT Grade CAR-T Manufacturing Service

Online Inquiry

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Chimeric Antigen Receptor (CAR) T cells are genetically engineered cells designed to recognize and attack cancer cells. Recent innovations in the design of various components of CAR structures, including the extracellular domain, transmembrane domain, and intracellular domain, have enhanced the efficacy and persistence of CAR-T cells. At the same time, researchers are exploring multiple target antigens to improve treatment outcomes and have proposed strategies involving dual-target or combination-target CAR-T cells to reduce the risk of relapse due to antigen escape. With advancements in manufacturing technologies and deeper research into CAR-T cells, there is potential for more efficient, safer, and cost-effective CAR-T cell therapies.

Creative Biolabs is at the forefront of providing integrated Contract Development and Manufacturing Organization (CDMO) services for CAR-T therapy, specifically tailored for Investigator Initiated Trials (IIT).

Comprehensive CDMO Services

Our IIT-grade CAR-T manufacturing services encompass a wide array of offerings designed to meet the diverse needs of our clients. Creative Biolabs offers a comprehensive range of CDMO services for CAR-T cells, leveraging our technology platform to provide high-quality, customized solutions throughout the process. Our services include dossier preparation for ethical and regulatory approvals, tailored process development and validation, and robust quality control measures. We ensure the production of CAR-T cells in a GMP-like environment, with scalable manufacturing capabilities. Additionally, we focus on maintaining storage and shipping stability according to specific project requirements, all while utilizing advanced automated culturing equipment to enhance cell proliferation and meet clinical standards. With extensive experience in manufacturing and supporting IND submissions, Creative Biolabs is committed to advancing cellular therapy products effectively and efficiently.

1-1-27-7-1-iit-grade-car-t-manufacturing-service-1

IIT-grade CAR-T Manufacturing at Creative Biolabs

Our services offer several significant advantages:

  • Cryopreserved Cell Preparation: Our independently developed methods ensure high-quality cell preparation.
  • Automated Culturing Equipment: We employ closed and automated systems that align with global industry standards, enhancing efficiency and consistency.
  • GMP Compliance: Our facilities adhere to stringent clinical and commercial requirements, ensuring high-quality production.
  • Improved Cell Proliferation: Our processes effectively address challenges related to low positive rates and proliferation rates.
  • Safety and Efficacy: Creative Biolabs implements a comprehensive set of quality control measures for CAR-T cells to ensure safety and efficacy throughout the manufacturing process.
  • Smoothness and Effectiveness: Creative Biolabs focuses on ensuring the smooth and effective execution of GMP projects through a dedicated team.

In recent years, CAR manufacturing technology has focused not only on reducing production time and improving cell quality but also on employing new technologies and gene editing techniques to enhance the anti-tumor capabilities and longevity of CAR-T cells. Creative Biolabs aims to adhere to established standards and requirements, facilitating the successful implementation of each project. We are looking forward to cooperating with you. Please contact us.

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.